These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17622926)

  • 61. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
    Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH
    Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164
    [No Abstract]   [Full Text] [Related]  

  • 62. eComment: Plasmapheresis for near-fatal heparin-induced thrombocytopenia.
    Knobloch K; Busche M; Busch KH
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):441. PubMed ID: 19304774
    [No Abstract]   [Full Text] [Related]  

  • 63. When is HIT really HIT?
    Warkentin TE; Crowther MA
    Ann Thorac Surg; 2007 Jan; 83(1):21-3. PubMed ID: 17184624
    [No Abstract]   [Full Text] [Related]  

  • 64. Platelet factor 4-heparin complexes trigger immune responses independently of the MyD88 pathway.
    Suvarna S; Qi R; Hollingsworth JW; Arepally GM
    Br J Haematol; 2008 Aug; 142(4):671-3. PubMed ID: 18510678
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT).
    Warkentin TE; Sheppard JI
    J Thromb Haemost; 2007 Mar; 5(3):636-7. PubMed ID: 17155944
    [No Abstract]   [Full Text] [Related]  

  • 66. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 67. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.
    Schreiber C; Dietrich W; Braun S; Kostolny M; Eicken A; Lange R
    Clin Res Cardiol; 2006 Jul; 95(7):379-82. PubMed ID: 16779503
    [No Abstract]   [Full Text] [Related]  

  • 69. Measurement of heparin-dependent platelet antibodies in the diagnosis of heparin-induced thrombocytopenia: fact or fiction?
    Parker RI
    Crit Care Med; 2007 Jul; 35(7):1784-5. PubMed ID: 17581366
    [No Abstract]   [Full Text] [Related]  

  • 70. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JI; Moore JC; Kelton JG
    J Thromb Haemost; 2010 Jan; 8(1):216-8. PubMed ID: 19818000
    [No Abstract]   [Full Text] [Related]  

  • 71. Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: use of heparin and epoprostenol combined with on-line monitoring of platelet function.
    Mertzlufft F; Kuppe H; Koster A
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):304-8. PubMed ID: 10890486
    [No Abstract]   [Full Text] [Related]  

  • 72. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
    Durand M; Lecompte T; Hacquard M; Carteaux JP
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
    Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery.
    Tsai HC; Yen HC; Hsu JC; Lin CL
    Br J Neurosurg; 2009 Feb; 23(1):95-6. PubMed ID: 19234918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.
    Bakchoul T; Zöllner H; Amiral J; Panzer S; Selleng S; Kohlmann T; Brandt S; Delcea M; Warkentin TE; Sachs UJ; Greinacher A
    Blood; 2013 Apr; 121(15):2821-7. PubMed ID: 23325832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Heparin-induced thrombocytopenia: 2002].
    Rák K
    Orv Hetil; 2003 Jun; 144(26):1275-7. PubMed ID: 12894671
    [No Abstract]   [Full Text] [Related]  

  • 78. Heparin-induced thrombocytopenia.
    Ortel TL
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):1-2. PubMed ID: 9855177
    [No Abstract]   [Full Text] [Related]  

  • 79. Heparin-induced thrombocytopenia: further evidence for a unique immune response.
    Pötschke C; Selleng S; Bröker BM; Greinacher A
    Blood; 2012 Nov; 120(20):4238-45. PubMed ID: 22932802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4).
    Meyer O; Salama A; Pittet N; Schwind P
    Lancet; 1999 Oct; 354(9189):1525-6. PubMed ID: 10551503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.